QF3-16221-13266
1 vaccination
1 coded response
14 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 328 / FL
- Registered
- 2021-04-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-11
Registered in v-safe
-
2021-04-11
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-12
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-04-13
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness, Dyspnoea — Feeling: GoodFree text: Shortness of breath & lightheaded (brief episode)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-25
- 2021-05-02
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-10-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-11 | Janssen/Johnson & Johnson |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Shortness of breath & lightheaded (brief episode)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release